Allaart C F, Rosendaal F R, Noteboom W M, Vandenbroucke J P, Briët E
Department of Haematology, University Hospital, RC Leiden, Netherlands.
BMJ. 1995 Oct 7;311(7010):910-3. doi: 10.1136/bmj.311.7010.910.
To establish the survival of individuals heterozygous for hereditary protein C deficiency, who have an increased risk of venous thrombotic events, and to compare it with the survival of the general population.
Retrospective study in pedigrees of 23 families with hereditary protein C deficiency for period 1820 and 1993.
23 completed family trees of 24 probands from various parts of the Netherlands with symptoms of protein C deficiency.
All 736 members of the 23 families with a 50% or 100% probability of being (or having been) heterozygous for the genetic defect on the basis of DNA analysis or their place in the pedigrees, following mendelian rules.
Observed mortality compared with the mortality of the general Dutch population; the standardised mortality ratio was calculated by dividing the observed mortality by the expected mortality.
No excess mortality was found in the 206 proved heterozygous individuals and "obligatory transmitters" (those who have definitely passed on the deficiency) (standardised mortality ratio 0.95 (95% confidence interval 0.5 to 1.2)) or in the 530 family members with a 50% genetic probability of heterozygosity (1.10 (0.9 to 1.3)).
Heterozygous individuals with hereditary protein C deficiency type I have normal survival compared with the general population. Prophylactic anticoagulant treatment may prevent thrombotic events in heterozygous individuals but may not be expected to improve their survival.
确定遗传性蛋白C缺乏杂合子个体的生存率,这类个体发生静脉血栓事件的风险增加,并将其与普通人群的生存率进行比较。
对1820年至1993年期间23个患有遗传性蛋白C缺乏症的家系进行回顾性研究。
来自荷兰各地的24名有蛋白C缺乏症状先证者的23个完整家系图谱。
根据DNA分析或家系中的位置,按照孟德尔遗传规律,23个家庭中所有736名成员有50%或100%的可能性是(或曾经是)该基因缺陷的杂合子。
观察到的死亡率与荷兰普通人群的死亡率进行比较;标准化死亡率通过将观察到的死亡率除以预期死亡率来计算。
在206名已证实的杂合子个体和“必然传递者”(那些肯定已传递该缺陷的个体)中未发现额外死亡率(标准化死亡率0.95(95%置信区间0.5至1.2)),在530名有50%遗传可能性为杂合子的家庭成员中也未发现额外死亡率(1.10(0.9至1.3))。
与普通人群相比,I型遗传性蛋白C缺乏杂合子个体的生存率正常。预防性抗凝治疗可能预防杂合子个体的血栓事件,但预计不会改善其生存率。